In conclusion, using an innovative and highly efficient screening approach we quickly identified two natural products (A and B) as potent cytotoxic molecules against human colorectal cancer cells, which exert resistance against anti-EGFR therapies. This evidence concerns the gene EGFR and colorectal cancer.